Wang, Xiaosheng
China Pharmaceutical University,
China
2024 Rank: 63517
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2056 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63517 | 66906 |
| Total Cites | 808 | 841 |
| H-index | 13 | 14 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 61 | 66 |
| Number of Single+First+Last Authored Papers | 94 | 94 |
| Total Cites to Single+First+Last Authored Papers | 766 | 797 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 761 | 771 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.09 |
| Self-Citation Percentage |
3.92%
|
|
Wang, Xiaosheng
China Pharmaceutical University,
China
2023 Rank: 58069
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Bioinformatics
Rank in SubField 1: 2071 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58069 | 52108 |
| Total Cites | 944 | 1023 |
| H-index | 12 | 15 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 4 | 5 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 66 | 73 |
| Number of Single+First+Last Authored Papers | 88 | 88 |
| Total Cites to Single+First+Last Authored Papers | 880 | 956 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 915 | 935 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.09 |
| Self-Citation Percentage |
7.72%
|
|
Wang, Xiaosheng
China Pharmaceutical University,
China
2022 Rank: 52715
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Bioinformatics
Rank in SubField 1: 2013 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52715 | 55962 |
| Total Cites | 952 | 1009 |
| H-index | 13 | 14 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 64 | 69 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 914 | 967 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 922 | 937 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.08 |
| Self-Citation Percentage |
5.65%
|
|
Wang, Xiaosheng
China Pharmaceutical University,
China
2021 Rank: 92272
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Bioinformatics
Rank in SubField 1: 3319 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92272 | 102022 |
| Total Cites | 950 | 991 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 101 | 105 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 906 | 942 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 919 | 938 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.06 |
| Self-Citation Percentage |
4.14%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.